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Abstract
Background: Parkinson’s disease (PD) is the most common neurodegenerative disorder. The diagnosis of PD is challenging
and currently none of the biochemical tests have proven to help in diagnosis. Serum metallomic analysis may suggest the
possibility of diagnosis of PD.
Methodology/Results: The metallomic analysis was targeted on 31 elements obtained from 42 healthy controls and 45
drug naive PD patients using ICP-AES and ICP-MS to determine the concentration variations of elements between PD and
normal. The targeted metallomic analysis showed the significant variations in 19 elements of patients compared to healthy
control (p,0.04). The partial least squares discriminant analysis (PLS-DA) showed aluminium, copper, iron, manganese and
zinc are the key elements, contributes the separation of PD patients from control samples. The correlation coefficient
analysis and element-element ratio confirm the imbalance of inter-elements relationship in PD patients’ serum.
Furthermore, elements linkage map analysis showed aluminium is a key element involved in triggering of phosphorus,
which subsequently lead to imbalance of homeostatic in PD serum. The execution of neural network using elements
concentrations provides 95% accuracy in detection of disease.
Conclusions/Significance: These results suggest that there is a disturbance in the elements homeostasis and inter-elements
relationship in PD patients’ serum. The analysis of serum elements helps in linking the underlying cellular processes such as
oxidative stress, neuronal dysfunction and apoptosis, which are the dominating factors in PD. Also, these results increase the
prospect of detection of early PD from serum through neural network algorithm.
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Introduction
Parkinson’s disease (PD) is a chronic neurodegenerative
disorder, characterized by a progressive loss of substantia nigra
pars compacta (SNc) neurons of unknown etiology [1]. The
diagnosis of PD is entirely clinical with no biochemical tests
presently available to diagnose PD. Current diagnosis is made by
standard neurological examination and medical history. The
severity of disease is categorized as stages based on the overall
motor function evaluation using the Unified Parkinson’s Disease
Rating Scale (UPDRS) or Hoehn and Yahr scale or Schwab and
England Activities of Daily Living Scale [2]. Three major cardinal
symptoms of PD are tremor, rigidity and motor dysfunction, which
significantly help in the detection of disease. However, the clinical
diagnosis fails to identify the PD before the significant loss of
dopamine neurons [3]. Hence, there is a need for early detection
and more effective drugs to stop the progression of nigral
degeneration [4].
Many decisions in medical practice are made by assessment of
biomarkers. Biomarker serves as a diagnostic tool usually performed
on body fluids, such as saliva, urine, serum or cerebrospinal fluid.
Several studies suggest the diagnosis of PD from serum/plasma
though the fundamental cause of disease is brain neurons [2,5].
Metallomics approach is greatly focused on the detection of element
markersforthediagnosisofdiseases.Elementsplayavitalroleinthe
biological system through their interaction with biomolecules.
Elements regulate a number of cellular metabolic reactions, while a
few of them act as etiological agents in many environmentally
induced neurological disorders [6,7]. Optimal concentration of
elements is required for proper functioning of the human system.
The deficiency of which causes serious metabolic abnormalities and
increase leads to toxicity. The variations in serum elements can be
potentially used for the diagnosis of diseases [8]. Several
encouraging results were obtained using element analysis in an
attempt to diagnose lung disease [9], hemochromatosis [10],
chronic kidney disease [11], renal failure [12], cardiovascular
disease [13] and liver disease [14].
In this study, an extensive analysis of 31 elements was made
using inductive coupled plasma atomic emission spectroscopy
(ICP-AES) and inductive coupled plasma mass spectroscopy (ICP-
MS). The analysis was carried out on 42 normal and 45 drug-
naive PD serum samples, to investigate the presence of variations
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(Ba), cadmium (Cd), calcium (Ca), cesium (Cs), chromium (Cr),
cobalt (Co), copper (Cu), fluorine (F), iodine (I), iron (Fe), lead (Pb),
mercury (Hg), magnesium (Mg), manganese (Mn), molybdenum
(Mo), nickel (Ni), phosphorus (P), potassium (K), rubidium (Rb),
selenium (Se), silicon (Si), silver (Ag), sodium (Na), strontium (Sr),
sulphur (S), titanium (Ti), tungsten (W), vanadium (V) and zinc
(Zn). The analysis was carried out on the early two stages of PD in
order to determine the early diagnosis of disease. Also, the aim was
to implement the concentrations of variable elements in artificial
neural network (ANN) for early and rapid detection of PD. The
results contribute to understand of metallomics dissimilarity
patterns in PD compared to healthy control.
Results
Investigation of serum samples for the detection of element
variations between normal and PD patients were performed using
ICP-AES and ICP-MS. The analysis of spectra aimed for 31 trace
and ultra trace elements (Ag, Al, As, Ba, Ca, Cd, Co, Cr, Cs, Cu,
F, Fe, Hg, I, K, Mg, Mn, Mo, Na, Ni, P, Pb, Rb, S, Se, Si, Sr, Ti,
V, W and Zn).The elements were selected based on the previous
elements interaction study [15], in order to make the element
linkage map for PD. The trace and ultra trace elemental
concentrations were expressed in terms of microgram/deciliter
(mg/dL). The comparative analysis revealed the variations in 22
elements. Silver (Ag), cadmium (Cd), cobalt (Co), iron (Fe),
rubidium (Rb), sulphur (S), selenium (Se) and zinc (Zn) were
decreased and increased aluminium (Al), calcium (Ca), chromium
(Cr), copper (Cu), mercury (Hg), potassium (K), magnesium (Mg),
manganese (Mn), molybdenum (Mo), sodium (Na), nickel (Ni),
phosphorus (P), lead (Pb) and vanadium (V) was noticed in PD
(Table 1). The concentrations of these elements were ranged from
0.0071 mg/dL for cadmium to 321000 mg/dL for sodium in PD
samples. The observed values obtained in this study was expressed
as the mean of 42 normal and 45 PD samples together with
standard deviation (SD) (Table 1).
Statistical analysis
Analysis of variance (ANOVA) was performed to demonstrate
the significance between the elements of control and PD (Table 1).
In PD, Al, Cu, K, Mn, Mo, Na, P and V were increased
significantly at p#0.01 and Ca, Hg, Mg, Ni and Pb were increased
significantly at p,0.05. The concentrations of Co, Fe, S, Se and
Zn were decreased significantly at p#0.01 and Cd was decreased
significantly at p,0.05 in patient samples. The elements, Cr, Ag
and Rb showed variations in concentrations with normal, were not
attained the minimal significance of p#0.05. The overall
probability values of these 19 significant elements were ranged
below 0.04 in PD serum compared to the control, which indicates
the possible imbalance in elemental homeostasis.
Element classification analysis
To explore the elements multidimensional data, unsupervised
PLS-DA method was executed. The PLS-DA analysis was carried
out on 19 significant variable elements of 87 samples. The analysis
Table 1. Significant variations in element concentration.
Elements Concentrations (mg/dL)
Reference Value Normal Disease
Al -- 0.19060.008 0.3260.07
Ag 0.018 0.01760.003 0.01060.004*
Ca
# 9250 84506720 106506340
Cd -- 0.011960.0004 0.007160.006
Co -- 0.0260.06 0.01460.02
Cr -- 0.01960.002 0.02860.003*
Cu 75 83689 8 63
Fe 119 12368 110.460.6
Hg -- 0.13660.021 0.19960.03
K
# 15000 142006 800 163006300
Mg
# 1750 1750620 2009643
Mn -- 0.0616 0.01 0.07660.004
Mo 0.15 0.0960.05 0.1960.02
Na
# 312000 30900063400 32100061100
Ni -- 0.03460.005 0.04460.003
P
# 11900 1080061200 1470061600
Pb -- 0.04860.003 0.06960.002
Rb 17 1563 01.760.7*
S- - 0 . 1 1 6 60.003 0.10460.002
Se 17 17631 . 8 60.4
V- - 0 . 0 0 5 60.0001 0.00960.0002
Zn 65 59674 3 64
*In significance (p.0.05); # trace analysis carried out using ICP-AES; -- Data not available.
doi:10.1371/journal.pone.0011252.t001
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drug-naive patients (Fig. 1). The loading coefficient map indicates
Al, Cu, Fe, Mn and Zn were dominantly responsible for the
separation of PD from normal (Fig. 2). Hence, the PLS-DA of
elements confirms the likely importance of elevated Al, Cu and
Mn and decreased concentrations of Fe and Zn for the diagnosis of
PD.
Element inter- relationship
In order to bring out the inter-relationship between the major
contributing elements, the element-element concentrations
ratios was executed. The element-element ratios help to
understand the interdependency of elements in the biological
system. The results suggest that t h er a t i o so fA l / C u ,A l / F e ,A l /
Mn, Al/Zn, Cu/Fe, Cu/Zn, Fe/Zn and Mn/Zn were increased
and Fe/Mn and Cu/Mn were decreased in PD compared to
healthy control (Table 2).
Linkage map analysis
The elements linkage map for PD was created using the
correlation coefficient values of 18 significant elements with the
understanding of previous elements interaction study [15].
Correlation coefficients were calculated using the concentrations
(mg/dL) of 18 significant elements of PD. Implementation of PD
correlation values in linkage map showed the variations in
interaction pattern between Cu vs (Fe and Mo), P vs (Mn, Pb
and Al), Se vs (Cu, Co and S), Zn vs (Pb, Fe and Ca), Ca vs Mg
and Mn vs V in PD compared to previous elements interaction
model (Fig. 3). In addition, few of the elements interactions are
insignificant (p.0.05) in correlation analysis (Table 3).
ANN model and its diagnostic performance
The ANN model described in methodology was tested with 23
samples. The results were compared with known clinical status.
The misclassification of one individual was noticed (Fig. 4). The
success rate of the classification network was 95% (22/23)
accuracy, whereas the specificity was 100% (11/11) and sensitivity
was 91% (11/12). Furthermore, the values generated by the
network are ranged from 0.1 to 1.0. Based on these values the
individuals were assigned as normal or PD. The individuals whose
final predicted values (x) #0.54 were assigned as normal and the
values (x) $0.55 were assigned as PD.
Discussion
Neurodegeneration in PD is a complex and multifaceted
process, affects a specific population of nerve cells. Elements play
a crucial role in the pathogenesis of neurodegeneration [16–22].
Several studies suggest that there is an elemental variation in
serum/plasma of PD [23–26]. However, there is an argument in
levels of variation in elements among these studies, which may be
due to a population variation. On understanding of those
variations, this study was focused on 42 normal and 45 PD
affected patients of South Indian population. The analysis was
carried out on 31 trace and ultra trace elements in the prospective
of diagnosis through neural-network algorithm. Targeted metal-
lomic analysis of serum showed differential distribution of 19
elements in drug naive patients compared to the healthy control
and reference elemental values (Table 1) [27]. Also, PLS-DA
analysis showed Al, Cu, Fe, Mn and Zn are the key elements
significantly contribute for the separation between the metallomics
Figure 1. PLS-DA analysis of normal and PD serum elements. PLS-DA score’s plot displays a significant separation between control subjects
(n=42) and unmedicated PD patients (n=45) using complete digital maps. The observations coded according to class membership: triangle is
normal and rhombus is PD. Each data point on a plot represents one individual.
doi:10.1371/journal.pone.0011252.g001
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Moreover, it was hypothesized that increased Al concentration
affects concentration of other elements by increasing the
concentration of Cu, Na, K, P and Mn and decreasing the
concentration of Fe, S, and Zn in serum [28]. Similar variation
patterns were also exhibited in this study.
The serum Al level was significantly increased in PD patients.
The Al concentration in our present investigation of control is
0.190 mg/dL and 0.32 mg/dL for PD. Al is a neurotoxin involved
in Ab aggregation, neuronal apoptosis and memory loss in animal
model [29,30]. The elevated serum Al concentration exhibits the
clinical symptom of depression [28]. Increased Al was found to
increase superoxide dismutase (SOD) activity to protect the cell
from oxidative stress [31]. The increased SOD was previously
reported in PD [32]. Furthermore, Al affects the integrity and
functionality of mitochondria and endoplasmic reticulum (ER),
which activates caspase-12 [33] that leads to endoplasmic
mediated cell death [34]. Our results also demonstrate the
increase Cu and decrease Zn. Similar trends were reported in
schizophrenic, bipolar and unipolar patients [28,35–38]. Cu is an
essential element for the activity of cytochromeC oxidase, Cu/Zn
superoxide dismutase and dopamine-beta-hydroxylase, which is
critical in scavenging reactive oxygen species. The increased Cu
generates reactive oxygen species which leads to oxidative stress
and contributes to the cell death pathway [39]. Additionally, the
serum Mn level was significantly increased in PD patients. Mn is
associated with mitochondrial dysfunction and DNA fragmenta-
tion of primary striatal neurons [40]. The malfunctioning of
Figure 2. Biomarker detection: Elements which are dominating the separation of disease from normal. The loading coefficient map
showing that aluminum, copper, iron, manganese, and zinc were predominantly responsible for the classification of groups. The blackened triangle
represents elements; grey circle represents normal (N) and Parkinson’s disease (P).
doi:10.1371/journal.pone.0011252.g002
Table 2. Homeostatic imbalance of elements in comparison
with control.
Elements X Elements Y
Element ratio in
normal
Element ratio in
PD
Al Cu 0.0022 0.0032
Al Fe 0.0013 0.0028
Al Mn 3.245 4.210
Al Zn 0.0030 0.007
Cu Fe 0.597 0.864
Cu Mn 1459 1289
Cu Zn 1.36 2.27
Fe Mn 2442 1492
Fe Zn 2.292 2.637
Mn Zn 0.00093 0.0017
doi:10.1371/journal.pone.0011252.t002
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cell death was still unclear in PD.
Our results demonstrate the decrease concentrations of Fe with
increase concentrations of Al in PD serum. Interestingly, similar
results were obtained in patients suffering from chronic fatigue
syndrome which affects cognition and influences neurological
abnormalities. Also, Fe plays a key role in oxidative stress [41] and
readily reduces hydrogen peroxide to liberate the reactive and
unselective hydroxyl radical, capable of inflicting severe oxidative
damage [42–44]. H2O2 is freely permeable across membranes and
readily inflicts oxidative damage to cells. Fe mediated increased
radicals promote mitochondrial dysfunction, oxidative stress and
neuron dysfunction [45]. Supportive of this finding, the animal
experiment showed an association between reduced Fe and
dopaminergic neurons [46].
Hence metallomics analysis of this study results in the imbalance
of elements concentrations leads to biochemical changes such as
oxidative stress, mitochondrial dysfunction and neuronal death in
PD. This elemental imbalance in serum may reflex in the
elemental concentrations of Zn, Al and Pb in the brain which
have been implicated in the aggregation of alpha-synuclein, a
crucial protein in Parkinson’s disease [47]. Also, it is notable that
there is an inter relationships between the elements that maintain
the homeostasis of biological system. Moreover, the abnormalities
of a single element concentration will affect the total element
distribution pattern in the biological system. For instance, the
results of element-to-element ratio of major contributing elements
showed the increase in ratios of Al/Cu, Al/Fe, Al/Mn and Al/Zn
in patients compared to control (Table 2). The abnormality in
elemental ratios may be due to increase in Al, which disturbs the
element homeostasis in serum by increasing the paramagnetic
oxidant elements like Cu and Mn while decreasing Zn, an
antioxidant metal required as a cofactor for CuZn–SOD and Zn–
thionein [28]. Furthermore, interdependency between the ele-
ments was validated using elements linkage map of previous study
[15].
The elements linkage map of PD was created by implementing
the significant correlation values of variable elements of PD in the
linkage map model. Of 19 significant elements 18 were configured
for linkage map analysis (Fig. 3). The element Na was excluded
from the interaction study due to lack of interaction data in the
model. The results show that the linkage map of previous model
and PD patients were similar although there were variations in
certain interaction pattern in PD patients. Nine significant
variations in interaction patterns were noticed in PD (Fig. 3).
Elements interaction between Cu vs Mo, P vs (Mn, Pb and Al), Se
vs (Cu, Co and S) and Zn vs (Pb and Fe) were altered as shown in
Figure 3. The interactions of F vs (Ca and Al) and Ti vs K were
not measured due to the insignificant concentration of F and Ti in
PD compared to healthy control.
In consideration of the Al hypothesis in PD linkage map
(Fig. 3), Al was observed to have interaction with F and P.
However, there is no significant variation in concentration of F
was noticed in PD compared to normal. Hence, it is
understandable that Al involved in triggering of P in PD.
Subsequently, P interacts with the Fe and Mn and altered their
concentrations significantly. Furthermore, the concentrations of
Cu and Zn may be altered by P via Pb. Also, the concentration
Figure 3. Element linkage map representing the interactions of elements. The interactions of 21 elements were configured. (A) Represents
the basic interaction occurs in mammals. (B) Represents the interactions in PD. The single head arrow indicates the increase of an element X, decrease
the element Y (negative correlation). The double headed arrow indicates, increase of an element X will increase the element Y or vice versa (positive
correlation). The blackened arrow indicates similar significant patterns in (A) and (B); gray arrows indicate significant variations in interaction in PD
and blackened dotted arrows indicate insignificant interaction. The grey box indicates insignificant variation in concentration between normal and
disease (ANOVA), and their interactions analysis was not carried out.
doi:10.1371/journal.pone.0011252.g003
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elements. Hence, Al mediated interaction of P plays a vital role in
the homeostasis of PD and increased serum Al concentration
might be related with the risk of PD.
The trace elements based diagnosis of PD was carried out using
ANN. The results showed there is a misclassification of one
diseased individual as normal (Fig. 4). The misclassification of this
pathological condition may be due to the variable data of age and
gender. The other variables of ANN were shown to be significant
in ANOVA and PLS-DA. Hence, age and gender may be the
major contributing factors for diagnosis. Few successful studies also
showed the relation of gender and age with PD [48,49]. However,
the ANN diagnosis of PD provides 95% accuracy, which is more
accurate than the current clinical diagnosis [2].
In conclusion, the present study of targeted metallomic profiling
showed the significant abnormalities in 19 circulating elements,
which help in linking the underlying cellular processes such as
oxidative stress, neuronal dysfunction and apoptosis, the domi-
nating factors in PD. Encouraging results were obtained in neural
network for rapid detection of PD. Further work needs to be
carried out in various populations to confirm the significance of
the neural network in detection of PD. However, in present status
it is suggested to execute a neural network along with a clinical
diagnosis, which will additionally improve the accuracy of PD
detection.
Materials and Methods
Sample collection
Clinical samples were collected from the out-patient setting of
the Department of Neurology at SRM Hospital, Tamil Nadu,
India. Drug-naive samples of 45 early PD patients were collected
and 42 samples of age and gender-matched healthy controls were
included for comparative study (Table 4). The written consent was
obtained from each participant during in-person interview and
blood donation. Data on gender, age, body mass index (BMI) and
family history of PD were recorded. All individuals chosen for this
study had no history of smoking, alcoholism, drug abuse and
antioxidant treatment for a period of seven months before sample
collection. The ethical committee of SRM Medical College
Hospital & Research, India reviewed and approved the protocol
of this study (Ref. No. 3496/Dean/07). The pathological status
was well studied by a qualified neurologist and the disease stages
were classified by UPDRS.
Collection and storage of samples
Blood samples were collected using intravenous canula from
individuals and immediately centrifuged for five min at
14,000 rpm to separate serum from other cellular materials.
Serum separations were carried out under HEPA filtered-air
condition and tubes used were polypropylened and no glass
material was used to prevent Al and Si contaminations. All
precautions to eliminate metal contamination during blood
collection and storage were taken in accordance with the National
Committee for Clinical Laboratory Standards (NCCLS) criteria
[50]. Subsequently, serum was transferred to fresh tube for the
ICP-AES and ICP-MS preparation. The serum was digested with
0.5 ml conc. HNO3 and dried using a hot air oven. The dried
serum was further dissolved with 5 ml of 0.1 M HNO3 solution
containing Ge, Rh and Re as internal standard. This solution was
immediately subjected to ICP-AES and ICP-MS to avoid
contaminations.
ICP-AES and ICP-MS Instrumentation
T h ed e t e r m i n a t i o no fN a ,K ,P ,C aa n dM gi nt h es e r u m
samples was carried out using ICP-AES. The ultra trace
elements were determined using ICP-MS instrument of Model
SPQ8000A (Seiko Instruments, Chiba), equipped with quadru-
ple mass spectrometer. The QA/QC of the instruments was
performed to confirm and to validate test methodology
including precision, accuracy and verifiable detection limits
before the execution of analysis. Quality control was performed
by analyzing a serum matrix matched multi-element synthetic
standard and certified standard reference material obtained
from the National Bureau of Standards, USA [51]. The
instrumental and operating conditions are summarized in
Table 5. The wavelengths of the emission line and mass
numbers for the analyte elements were used in ICP-AES and
Table 3. Element inter-relationship in PD for element linkage
map.
Number of
interaction Element X Element Y
Degree of
correlation in PD
1 Ca Mg 0.234*
2C aP 20.789
3C uM o20.397
4C uC d20.802
5C uN i 20.973
6 Cu Zn 0.922
7C uC a20.267*
8 Cu Pb 0.737
9 Cu Fe 0.289*
10 Cd Co 20.188*
11 Cd Fe 20.802
12 Cd Ca 20.359
13 Cd Zn 20.970
14 Fe Mn 0.397
15 Fe Pb 20.433
16 Fe P 20.338*
17 Fe Zn 0.636
18 Fe Co 0.866
19 Mn P 0.729
20 Mn V 0.0821*
21 Mn Ca 20.155*
22 P Al 20.957
23 Pb P 0.994
24 Pb Ca 20.848
25 S Mo 20.755
26 Se Cd 20.970
27 Se Cu 0.636
28 Se Co 0.419
29 Se Hg 0.090*
30 Se S 0.907
31 Zn Ni 20.986
32 Zn Pb 0.419
33 Zn Ca 0.124*
*Insignificance (p.0.05).
doi:10.1371/journal.pone.0011252.t003
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for each element in such a way that interference from the other
elements was at minimum.
Statistical analyses
The elements profiled data was imported into GeneSpring
GX7.3 microarray software (Agilent Technologies Inc., Santa
Clara, California), in which the analysis of variance (ANOVA) was
performed. In order to confirm the biomarkers differentiating the
patients from matched controls, PLS-DA was employed using
Umatrices software (Umetrics, Inc., Kinnelon, NJ). The correla-
tion coefficient and element-to-element ratios were calculated
using Microsoft Excel 2003. The PD network map was created
using the correlation coefficient values and mammalian network of
previous study [15].
Artificial Neural network (ANN)
A NeuNet Pro software (CorMac Technologies Inc., Canada)
was used for the ANN prediction. The ANN adopted in this study
was three-layered network of back propagation algorithm. The
input layer consisted of seven neurons (age, gender and
concentrations of aluminium, copper, iron, manganese and zinc).
The hidden layer, with six units, and an output layer, whose
output values ranged from 0 to 1 indicating the likelihood of PD.
The network was trained with variable data of randomly selected
64 individuals (31 normal and 33 PD) from the set of 87, with
known pathological information. The training process continued
until the difference between the ANN classification and clinical
diagnosis became diminished. Once the network was trained, the
remaining 23 individuals were tested using the trained network.
The outcome of classification results was then compared to clinical
data to determine the classification ability of the network.
Figure 4. Neural network predication. Neural network classification of 23 individuals (x-axis) with known clinical information. Values (y-axis) are
predicted over the trained network and are 0.1 to 1; values (x) #0.54 reflect a neural-network classification of ‘‘normal,’’ and values (x) $0.55 reflect a
neural-network classification of PD. Individuals denoted by a triangle = normal, circle = PD and square = misdiagnosed individual.
doi:10.1371/journal.pone.0011252.g004
Table 4. Statistics of research participant’s involved in study.
Sample information Number of samples Mean age in years±SD Gender
Male Female
Normal 42 55.6263.25 25 17
PD 45 57.6269.10 26 19
doi:10.1371/journal.pone.0011252.t004
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